Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
The U.S. economy got some good news last week when the unemployment rate fell to its lowest level in almost three years. But the job growth hasn’t reached over five million Americans who have been out of work for more than six months. Federal reserve chairman Ben Bernanke this week said record levels of the long-term unemployed will alter this country’s job market for the worse for the foreseeable future. Just who are those left behind as the economy improves and what are their options to get past their seemingly hopeless situation? Diane and her panel look at the challenges for the long-term unemployed.
- Derek Thompson senior editor at the Atlantic
- Ingrid Schroeder director of the Pew Fiscal Analysis Initiative
- Stephen Rose research professor at the Georgetown University Center on Education and the Workforce
- William Rodgers III professor of public policy and chief economist at the Heldrich Center for Workforce Development at Rutgers University
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.